1-(3-chlorophenyl)piperazine has been researched along with vanoxerine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayestas, MA; Baumann, MH; Dersch, CM; Partilla, JS; Rothman, RB | 1 |
1 other study(ies) available for 1-(3-chlorophenyl)piperazine and vanoxerine
Article | Year |
---|---|
Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
Topics: Analysis of Variance; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Fenfluramine; Male; Microdialysis; Models, Neurological; Neurotoxicity Syndromes; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Tritium | 2000 |